{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:25:39Z","timestamp":1761017139721,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vascn.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T02:48:38Z","timestamp":1463453318000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["How to determine cardiac ion channels targeted by drugs using the isolated rabbit ventricular wedge model"],"prefix":"10.1016","volume":"81","author":[{"given":"Guizhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan-Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2016.05.008_bb0005","first-page":"315","article-title":"Mexiletine prevents recurrent torsades de pointes in acquired long QT syndrome refractory to conventional measures","volume":"1","author":"Badri","year":"2015","journal-title":"ACCCEP"},{"key":"10.1016\/j.vascn.2016.05.008_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vascn.2013.04.004","article-title":"Evaluation of an in silico cardiac safety assay: Using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge","volume":"68","author":"Beattie","year":"2013","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.05.008_bb0015","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/AAC.05688-11","article-title":"In vitro cardiovascular effects of dihydroartemisin-piperaquine combination compared with other antimalarials","volume":"56","author":"Borsini","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.vascn.2016.05.008_bb0020","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s004240050240","article-title":"Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B","volume":"432","author":"Busch","year":"1996","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.vascn.2016.05.008_bb0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.hrthm.2012.12.017","article-title":"Pro- and antiarrhythmic effects of ATP-sensitive potassium current activation on reentry during early afterdepolarization-mediated arrhythmias","volume":"10","author":"Chang","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2016.05.008_bb0030","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2016.05.008_bb0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCEP.113.000092","article-title":"Inhibition of late sodium current by mexiletine: A novel pharmotherapeutical approach in timothy syndrome","volume":"6","author":"Gao","year":"2013","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0040","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.hrthm.2010.12.026","article-title":"Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents","volume":"8","author":"Guo","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2016.05.008_bb0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1540-8167.2006.00698.x","article-title":"L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation","volume":"18","author":"Guo","year":"2007","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jelectrocard.2008.07.016","article-title":"T(p-e)\/QT ratio as an index of arrhythmogenesis","volume":"41","author":"Gupta","year":"2008","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kft113","article-title":"Comparison of electrophysiological data from human-induced pluripotent stem cell\u2013derived cardiomyocytes to functional preclinical safety assays","volume":"134","author":"Harris","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2016.05.008_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","author":"Investigators","year":"1989","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2016.05.008_bb0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1476-5381.2010.01181.x","article-title":"Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade","volume":"164","author":"Jia","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"Suppl","key":"10.1016\/j.vascn.2016.05.008_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jelectrocard.2004.08.003","article-title":"Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: The role of experimental models","volume":"37","author":"Joshi","year":"2004","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.hrthm.2006.04.021","article-title":"Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias","volume":"3","author":"Liu","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2016.05.008_bb0080","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.hrthm.2012.06.030","article-title":"Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: A blinded validation","volume":"9","author":"Liu","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2016.05.008_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1476-5381.2010.00646.x","article-title":"Predicting drug-induced slowing of conduction and pro-arrhythmia: Identifying the \u2018bad\u2019 sodium current blockers","volume":"160","author":"Lu","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2006.09.035","article-title":"In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation","volume":"553","author":"Lu","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.RES.35.3.439","article-title":"A dissociation of positive staircase (Bowditch) from ouabain-induced positive inotropism","volume":"35","author":"McCans","year":"1974","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.008_bb0100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.109.858027","article-title":"Dronedarone","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0105","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.hrthm.2015.02.013","article-title":"Heterogeneous distribution of INa-L determines interregional differences in rate adaptation of repolarization","volume":"12","author":"Qi","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2016.05.008_bb0110","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2016.05.008_bb0115","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/bjp.2008.238","article-title":"Cellular basis of drug-induced torsades de pointes","volume":"154","author":"Roden","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0120","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.yjmcc.2010.11.017","article-title":"A novel mutation in the KCNH2 gene associated with short QT syndrome","volume":"50","author":"Sun","year":"2011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2008.02.009","article-title":"Preclinical assessment of drug-induced proarrhythmias: Role of the arterially perfused rabbit left ventricular wedge preparation","volume":"119","author":"Wang","year":"2008","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.008_bb0135","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1540-8167.2005.40720.x","article-title":"Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes","volume":"16","author":"Wu","year":"2005","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/01.CIR.103.11.1585","article-title":"Left ventricular hypertrophy decreases slowly, but not rapidly activating delayed rectifier K+ currents of epicardial and endocardial myocytes in rabbits","volume":"103","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.CIR.93.2.372","article-title":"Cellular basis for the electrocardiographic J wave","volume":"93","author":"Yan","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0150","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.98.18.1928","article-title":"Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome","volume":"98","author":"Yan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0155","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0160","first-page":"H1968","article-title":"Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early after depolarization","volume":"281","author":"Yan","year":"2001","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.vascn.2016.05.008_bb0165","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.CIR.103.23.2851","article-title":"Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: Direct evidence from intracellular recordings in the intact left ventricular wall","volume":"103","author":"Yan","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0170","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/01.CIR.0000140258.09964.19","article-title":"Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia","volume":"110","author":"Yan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.008_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0735-1097(03)00713-7","article-title":"Ventricular repolarization components on the electrocardiogram: Cellular basis and clinical significance","volume":"42","author":"Yan","year":"2003","journal-title":"Journal of the American College of Cardiology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687191630048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687191630048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:20Z","timestamp":1761004820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687191630048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":35,"alternative-id":["S105687191630048X"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2016.05.008","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to determine cardiac ion channels targeted by drugs using the isolated rabbit ventricular wedge model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}